Latest news for DermTech (OTC:DMTKQ) Stock

DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.

DermTech Inc

Cantor Fitzgerald analyst Andres Sheppard reiterates Lucid Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) with a Underweight and maintains $4 price target.

News

Price Target

Reiteration

Analyst Ratings

LCID

Cantor Fitzgerald Reiterates Underweight on Lucid Gr, Maintains $4 Price Target

Wolfe Research analyst Timna Tanners downgrades Vale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) from Outperform to Peer Perform.

Downgrades

VALE

Wolfe Research Downgrades Vale to Peer Perform

Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) has outperformed the market over the past 20 years by 11.28% on an annualized basis producing an average annual return of 19.81%. Currently, Gartner has a market capitalization of $35.44 billion. 
Buying $1000 In IT: If an investor had bought $1000 of IT stock 20 years ago, it would be worth $36,651.66 today based on a price of $456.52 for IT at the time of writing.
<h3>Gartner's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721230217_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $1000 Invested In Gartner 20 Years Ago Would Be Worth Today

Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) has outperformed the market over the past 20 years by 2.0% on an annualized basis producing an average annual return of 10.52%. Currently, Welltower has a market capitalization of $63.54 billion. 
Buying $1000 In WELL: If an investor had bought $1000 of WELL stock 20 years ago, it would be worth $7,161.04 today based on a price of $106.27 for WELL at the time of writing.
<h3>Welltower's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721230211_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

WELL

$1000 Invested In Welltower 20 Years Ago Would Be Worth This Much Today

401(k) plans are among the most popular ways Americans save for retirement. They&#8217;re so widely used because they offer great benefits like tax advantages, employer match programs, and the ability to automatically deduct savings directly from your paycheck, making it easier to save consistently. For many, these plans are crucial to achieving a secure retirement.
Don't Miss:
<ul>
<li>Are you richer than most people you know?<a href="https://www.benzinga.com/money/are-you-richer-than-most-people"> Here&#8217;s the net worth you need at every age to be above average.</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
</ul>
Understanding where you stand with your <a href="https://www.benzinga.com/personal-finance/24/06/39510803/average-401-k-balances-fall-short-across-all-ages-many-over-50-barely-have-enough-to-buy-a-new-c">401(k) savings</a> compared to where you should be can help you make necessary adjustments to meet your financial goals for retirement. It&#8217;s important to remember that the average or median account balances you often hear about might not directly apply to you. These figures can provide a benchmark, but the right savings target depends on your <a href="https://www.benzinga.com/personal-finance/financial-advisors/24/01/36745517/if-someone-has-a-500-000-401-k-and-plans-to-work-part-time-can-they-afford-to">personal goals, lifestyle, and retirement plans</a>.
Here's a breakdown of what most people have in their 401(k) by age compared to what experts suggest aiming for:
Under 25 Years Old: The average balance is around $5,236, with a median of $1,948. At this stage, the focus should be on saving anything you can, especially to take advantage of compound interest over time.
Ages 25-34: On average, balances grow to about $30,017, with a median of $11,357. Financial advisors often suggest aiming to have the equivalent of your annual salary saved by age 30.
Ages 35-44: The average 401(k) balance is $76,354, and the median is $28,318. By age 40, having three times your annual income saved is a recommended target to stay on track for a comfortable retirement.
Ages 45-54: People in this group have an average balance of $142,069 and a median of $48,301. By the time you hit 50, aiming for six times your annual income can set you up for a more secure retirement.&nbsp;
Ages 55-64: The average jumps to $207,874, with a median of $71,168. Financial guidance often suggests having at least eight times your annual salary saved by age 60.
Trending: Rory McIlroy&#8217;s mansion in Florida is worth $22 million today, doubling from 2017 —<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> here&#8217;s how to get started investing in real estate with just $100</a>
Determining how much to contribute to your 401(k) each year depends on your unique financial situation and goals. A general guideline is to contribute 10% to 15% of your salary, including any employer contributions, starting around age 25.
While a 401(k) is a great retirement savings option, it might not be the only one you need. Depending on your income and situation, an Individual Retirement Account (IRA) could be a valuable addition to your retirement savings plan. IRAs offer tax advantages similar to 401(k)s and may have more investment flexibility.&nbsp;
Everyone's situation is unique. Although most Americans <a href="https://www.benzinga.com/personal-finance/24/05/39009115/rich-americans-say-they-need-4-million-to-retire-should-you-aim-for-this-too">feel they need nearly $1.5 million to retire</a>, some can do it far less while others might need much more.&nbsp;
If you're behind on your personal savings goal, it's not too late to make changes and boost those numbers. According to Forbes, "The reality is most people could be saving more." Although this may be questionable for some, others find they could truly be saving more.&nbsp;
<a href="https://www.benzinga.com/money/are-you-rich">Consider talking to a financial advisor</a> to create a personalized retirement savings plan. An advisor can also help you explore all the various retirement savings options.
Read Next:
<ul>
<li>Many are surprised by Mark Cuban&#8217;s advice for lotto winners:<a href="https://www.benzinga.com/money/mark-cubans-annuity-adv"> Cash or annuity?</a></li>
<li>Warren Buffett flipped his neighbor's $67,000 life savings into a $50 million fortune —<a href="https://www.benzinga.com/money/advisor-adv-warren-buffett"> How much is that worth today?</a></li>
</ul>

Personal Finance

Do You Know How Much You Should Have In Your 401(k)? Here's What Experts Recommend Vs. The Actual Average Balance At Every Age

HSBC analyst Santhosh Seshadri downgrades Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) from Buy to Hold and announces $95 price target.

HSBC Downgrades Albemarle to Hold, Announces $95 Price Target

Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) shares are trading lower by 7% to $228.61 during Wednesday&#8217;s session. Shares of several semiconductor stocks are trading lower amid reports President Biden is considering <a href="https://www.benzinga.com/markets/equities/24/07/39813495/why-key-apple-nvidia-supplier-tsmcs-shares-are-plunging-in-wednesdays-premarket">further China restrictions</a> and following Republican nominee Donald Trump's comments regarding the China-Taiwan standoff in an interview with Bloomberg. The sector may also be down following <a href="https://www.benzinga.com/news/24/07/39813829/asml-reports-q2-results-joins-spirit-airlines-and-other-big-stocks-moving-lower-in-wednesdays-pre-ma">soft guidance</a> from ASML.
Trump&#8217;s remarks regarding Taiwan&#8217;s dominant role in the U.S. chip industry and the outsourcing of manufacturing to Taiwan created concerns about potential political and economic instability. His comments suggested a possible shift in U.S. policy towards Taiwan, which could disrupt the semiconductor supply chain. 
This geopolitical tension can cause investors to fear disruptions in the supply chain and potential tariffs or sanctions, affecting companies like Applied Materials that supply equipment to chip manufacturers.
ASML, another significant player in the semiconductor equipment industry, issued a less-than-optimistic forecast. ASML&#8217;s cautious outlook suggests potential challenges in the semiconductor market, such as reduced demand or technological and production hurdles. 
This adds to the negative sentiment, impacting other companies in the industry, including Applied Materials.
Read Also: <a href="https://www.benzinga.com/government/24/07/39810709/whats-going-on-with-alibaba-and-peer-chinese-stocks-on-wednesday">What&#8217;s Going On With Alibaba And Peer Chinese Stocks On Wednesday?</a>
<h2 class="wp-block-heading">How To Buy AMAT Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Applied Materials&#8217; case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
AMAT has a 52-week high of $255.89 and a 52-week low of $129.21.

AMAT

Why Applied Materials (AMAT) Stock Is Getting Hammered

Barclays analyst Theresa Chen maintains Cheniere Energy Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CQP#NYSE">CQP</a>) with a Underweight and raises the price target from $45 to $46.

Barclays Maintains Underweight on Cheniere Energy Partners, Raises Price Target to $46

QUALCOMM Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) shares are trading lower Wednesday following a downgrade from HSBC. Here&#8217;s what <a href="https://www.benzinga.com/analyst-stock-ratings">you need to know</a>.
What To Know: HSBC analyst Frank Lee downgraded Qualcomm from Buy to Hold and set a price target of&nbsp;$200 ahead of earnings due in about two weeks.
Qualcomm is set to report financial results after the market close on July 31. According to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>, the company is expected to report earnings of $2.25 per share and revenue of $9.212 billion. 
Last quarter, Qualcomm <a href="https://www.benzinga.com/news/earnings/24/05/38563793/qualcomm-q2-earnings-highlights-revenue-beat-eps-beat-record-automotive-results-on-device-ai-growth#">beat analyst estimates</a> on the top and bottom lines and issued strong guidance for the third quarter. The company guided for revenue of $8.8 billion to $9.6 billion and earnings of $2.15 to $2.35 per share. 
&#8220;We are excited about our continued growth and diversification, including achieving our third consecutive quarter of record QCT Automotive revenues, upcoming launches with our Snapdragon X platforms, and enabling leading on-device AI capabilities across multiple product categories,"&nbsp;the company said at the time. 
See Also: <a href="https://www.benzinga.com/news/earnings/24/07/39814804/unitedhealth-analysts-boost-their-forecasts-following-upbeat-earnings">UnitedHealth Analysts Boost Their Forecasts Following Upbeat Earnings</a>
Susquehanna analyst Christopher Rolland on Wednesday maintained Qualcomm with a <a href="https://www.benzinga.com/analyst-stock-ratings">Positive rating</a> and raised the price target from&nbsp;$205&nbsp;to&nbsp;$250. Here&#8217;s a look at other positive analyst changes over the past two weeks.
<ul>
<li>Cantor Fitzgerald analyst C J Muse maintained Qualcomm with a Neutral and raised the price target from&nbsp;$190&nbsp;to&nbsp;$215.</li>
</ul>
<ul>
<li>Citigroup analyst Christopher Danely maintained Qualcomm with a Neutral and raised the price target from&nbsp;$170&nbsp;to&nbsp;$200.</li>
</ul>
<ul>
<li>Keybanc analyst John Vinh maintained Qualcomm with an Overweight and raised the price target from&nbsp;$205&nbsp;to&nbsp;$225.</li>
</ul>
Qualcomm also announced its <a href="https://www.benzinga.com/pressreleases/24/07/b39814784/qualcomm-announces-quarterly-cash-dividend">quarterly cash dividend</a> on Wednesday. The company declared a dividend of 85 cents per common share, payable on Sept. 26 to shareholders of record as of Sept. 5. 
QCOM Price Action: Qualcomm shares were down 6.29% at $196.46 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Movers

QCOM

Qualcomm Stock Is Moving Lower Wednesday: What's Going On?

Charles Schwab Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) is under pressure Wednesday after the investing giant warned it will need to become smaller in an effort to protect profitability. Analysts are <a href="https://www.benzinga.com/news/earnings/24/07/39815112/these-analysts-cut-their-forecasts-on-charles-schwab-after-q2-results">cutting estimates as a result</a>.
What To Know: Before the market open on Tuesday, Schwab reported second-quarter revenue of $4.69 billion, beating analyst estimates of $4.68 billion. The company also turned in adjusted earnings of 73 cents per share, beating estimates of 72 cents per share, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Following the print, JPMorgan analyst Kenneth Worthington cut the firm&#8217;s price target from $82 to $78 on lower 2025 adjusted earnings expectations. The analyst previously forecasted full-year earnings of $4.81 per share, but now anticipates $4.57 per share.
&#8220;While the headline results were largely in line, underlying trends across net new asset growth, interest earning assets, the lack of short-term funding paydown, and lingering (but improving) cash sorting were disappointing,&#8221; Worthington said in a note to clients. 
Furthermore, commentary on a vision for a smaller bank is likely fueling some of the selling pressure on shares as investors question management conviction, the analyst said, adding that the print was &#8220;sobering&#8221; on multiple fronts.
&#8220;The pace of short-term debt paydown and the timing of sustainable net new asset growth re-acceleration remain key variables for Schwab's return to normalization — and we are not yet seeing the light at the end of the tunnel here,&#8221; Worthington said. 
See Also: <a href="https://www.benzinga.com/news/earnings/24/07/39793390/schwabs-asset-management-fees-soar-but-interest-income-decline-weighs-on-q2-details">Schwab&#8217;s Asset Management Fees Soar, But Interest Income Decline Weighs on Q2: Details</a>
Despite cutting estimates, the JPMorgan analyst still believes the path to recovery remains intact. Worthington highlighted positive commentary regarding the <a href="https://www.benzinga.com/news/earnings/19/11/14874156/schwab-td-ameritrade-confirm-26b-all-stock-merger">Ameritrade transaction</a> and noted that management maintained key medium-term targets around organic growth and net interest margin. 
Goldman Sachs also weighed in on Schwab following the lackluster report. Analyst Alexander Blostein<a href="https://www.benzinga.com/analyst-stock-ratings"> lowered the firm&#8217;s price target</a> from $75 to $71 and cut EPS estimates to reflect a slower pace of supplemental borrowing pay down and push out on capital returns.
The analyst highlighted elevated deposit outflows at the end of the quarter and an incremental uptick in short-term funding following elevated client engagement as reasons why he continues to believe Schwab remains on a &#8220;choppy path&#8221; to EPS growth. 
&#8220;We continue to think the upside remains largely dependent on sweep deposit stabilizing and eventually growing, with both magnitude and timing here remaining less certain. Until we see sustained growth in deposits, we think the restructuring of SCHW's securities portfolio is unlikely and timing of share repurchases will continue to get pushed out,&#8221; Blostein said in the note.
SCHW Price Action: <a href="https://www.benzinga.com/quote/SCHW">Schwab shares</a> were down 6.20% at $63.25 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39813486/top-3-financials-stocks-that-could-blast-off-in-q3">Top 3 Financials Stocks That Could Blast Off In Q3</a></li>
</ul>
Photo: Shutterstock.

Analyst Color

Earnings

SCHW

Charles Schwab Analysts See 'Choppy Path' For Bank After Q2 Earnings: 'We Are Not Yet Seeing The Light At The End Of The Tunnel'

Barclays analyst Marc Solecitto maintains Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) with a Overweight and raises the price target from $194 to $199.

Barclays Maintains Overweight on Cheniere Energy, Raises Price Target to $199

Barclays analyst Jason Goldberg maintains Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) with a Overweight and raises the price target from $43 to $49.

Barclays Maintains Overweight on Bank of America, Raises Price Target to $49

LexisNexis launched a research tool Wednesday that uses artificial intelligence to boost <a href="https://www.benzinga.com/topic/artificial-intelligence">corporate research capabilities</a>.
The information research company, a subsidiairy of RELX PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RELX#NYSE">RELX</a>), has developed Nexis+ AI, a research platform that provides access to more than 20,000 news providers such as The Associated Press, Gannett, McClatchy, Benzinga and FiscalNote &#8211; CQ Roll Call. 
The technology, which is offered through LexisNexis Legal &amp; Professional, is designed to allow end users to research and analyze business, financial and legal information and news, extract relevant information from lengthy documents and summarize and share content.
It can also create first drafts and outlines of intelligence reports and quickly come up with business insights, LexisNexis said.
"Business leaders across nearly every industry tell us they need deeper, more accurate insights to better facilitate timely decisions, but they find the amount of corporate data daunting and the process time consuming. Todd Larsen, president of Nexis Solutions, said in a statement.
Also Read: <a href="https://www.benzinga.com/news/24/07/39810790/as-nvidia-microsoft-and-google-lead-ai-boom-taiwans-chief-telecom-president-calls-for-entirely-new-d">As Nvidia, Microsoft, And Google Lead AI Boom, Taiwan&#8217;s Chief Telecom President Calls For &#8216;Entirely New&#8217; Data Center Infrastructure</a>
&#8220;Recognizing this, we've created Nexis+ AI to accelerate data-intensive research and strategic decision-making.&#8221;
LexisNexis said AI+ Nexis also features intellectual property and copyright protection through longstanding, and in some cases exclusive, content licensing agreements with publishers that provides direct links to original source material.
Earlier this year, LexisNexis tested Nexis+ AI&#8217;s commercial application on a number of organizations that included large corporations, financial institutions and six major consulting firms to ensure further refinement of the platform.
"The launch of Nexis+ AI represents a significant first milestone in our mission to provide organizations with the tools they need to accelerate company research and make informed business decisions," said Dani McCormick, vice president of product for Nexis Solutions.
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39813495/why-key-apple-nvidia-supplier-tsmcs-shares-are-plunging-in-wednesdays-premarket">Why Key Apple, Nvidia Supplier TSMC&#8217;s Shares Are Plunging In Wednesday&#8217;s Premarket</a></li>
</ul>
Illustration via Pixabay.

Tech

AADR

APIE

IDVO

PowerShares ETF Trust International Dividend Achievers Portfolio

PRAY

RELX

LexisNexis Legal & Professional Launches AI Research Tool Nexis+ AI

Barclays analyst Jiong Shao maintains Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) with a Overweight and lowers the price target from $133 to $125.

BIDU

Barclays Maintains Overweight on Baidu, Lowers Price Target to $125

Omnicom Group Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMC#NYSE">OMC</a>) shares are trading lower today after the company reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/n39803268/omnicom-reports-second-quarter-2024-results" rel="noreferrer noopener">second-quarter FY24 results</a>.
Revenue rose&nbsp;6.8%&nbsp;Y/Y to&nbsp;$3.85 billion, beating the consensus of&nbsp;$3.82 billion.
This was led by an organic growth of&nbsp;5.2%&nbsp;Y/Y. Acquisition revenue (net of disposition revenue) increased revenue by&nbsp;2.6% Y/Y, led by Flywheel Digital's acquisition in the Precision Marketing discipline, and the impact of foreign currency translation reduced revenue by&nbsp;1.0%.
Adjusted EBITA rose&nbsp;5.5%&nbsp;Y/Y to&nbsp;$589.6 million, with the margin decreasing to&nbsp;15.3% from 15.5%&nbsp;a year ago. Adjusted EPS of&nbsp;$1.95&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">beat the consensus of&nbsp;$1.93</a>.
Organic growth by discipline &#8211; 17.6% Y/Y in Experiential, 7.8% Y/Y in Advertising &amp; Media, 2.0% Y/Y in Healthcare, 1.4% Y/Y in Precision Marketing, 1.2% Y/Y for Execution &amp; Support and 0.9% Y/Y for Public Relations.
By region, organic revenue grew 24.5% Y/Y in&nbsp;Latin America, 8.0% Y/Y in the&nbsp;Middle East&nbsp;&amp;&nbsp;Africa, 6.9% Y/Y in the&nbsp;United Kingdom, 6.3% Y/Y in&nbsp;the United States and 4.5% Y/Y in Euro Markets &amp; Other Europe.
&#8220;With the rapid adoption of Gen AI, creativity and talent matter more than ever to address the breadth and complexity of consumers,&#8221; CEO John Wren said. 
Price Action: OMC shares are down 4.83%&nbsp;at&nbsp;$90.79&nbsp;at the last check Wednesday.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/real-estate/reit/24/07/39816656/fed-rate-cut-expectations-drop-mortgage-rates-to-4-month-lows-surge-in-new-applications-refinanc">Fed Rate Cut Expectations Drop Mortgage Rates To 4-Month Lows: Surge In New Applications, Refinance Demand</a></li>
</ul>
Image: Shutterstock

Equities

Large Cap

Why Media Company Omnicom Shares Are Diving Today

Barclays analyst Theresa Chen upgrades TC Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TRP#TSX">TRP</a>) from Equal-Weight to Overweight and raises the price target from C$55 to C$61.

Upgrades

TSX:TRP

Barclays Upgrades TC Energy to Overweight, Raises Price Target to C$61

Winmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINA#NASDAQ">WINA</a>) reported quarterly earnings of $2.85 per share. This is unchanged from the same period last year. The company reported $20.12 million in sales this quarter. This is a 1.19 percent decrease over sales of $20.36 million the same period last year.

WINA

Winmark Q2 EPS $2.85, Same YoY, Sales $20.12M Down From $20.36M YoY

Barclays analyst Theresa Chen reinstates Kodiak Gas Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGS#NYSE">KGS</a>) with a Equal-Weight and announces $29 price target.

Initiation

Barclays Reinstates Equal-Weight on Kodiak Gas Services, Announces $29 Price Target

Macro Economic Events

WIIM

Economics

The Nasdaq is lower amid a selloff in semiconductor stocks.

Intel Capital, the venture arm of Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), is standing out as a notable foreign investor in <a target="_blank" href="https://www.benzinga.com/topic/artificial-intelligence" rel="noreferrer noopener">Chinese AI and semiconductor startups</a>.
This comes as the $147 billion chipmaker is receiving major funding from Washington to compete technologically with Beijing.
Intel's involvement in Chinese tech, particularly AI, has raised national security concerns in the U.S.
Globally, the venture arm has deployed over $20 billion since the 1990s under the leadership of Anthony Lin in San Francisco.
Intel Capital has stakes in 43 China-based tech startups. Since its formation, the venture fund has invested in over 120 Chinese companies, reported <a target="_blank" href="https://www.ft.com/content/0217cab2-c9a3-4ffa-993a-39874d6d803f" rel="noreferrer noopener">Financial Times</a>.
Earlier this year, Intel Capital participated in a $20 million fundraising for Shenzhen-based AI-Link, a 5G and cloud infrastructure firm and had led a $91 million funding round for Shanghai's micro-optics hardware producer, North Ocean Photonics, in 2022.
In June, the Biden administration announced new rules to limit <a target="_blank" href="https://www.benzinga.com/markets/asia/24/06/39279319/biden-mulls-new-restrictions-on-chinas-advanced-ai-chips-access-report" rel="noreferrer noopener">U.S. financing for Chinese technology</a> with potential military applications. The rules, whose primary target is AI and quantum computing, are expected to be sealed this year.
The company has notably slowed its Chinese investments, completing only three deals since early 2023, FT report says.
Intel Capital's portfolio in China includes 16 AI startups and 15 semiconductor companies, among others, according to the report.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/07/39746962/chip-maker-intel-aims-for-1b-in-software-revenue-by-2027" rel="noreferrer noopener">Chip Maker Intel Aims For $1B In Software Revenue By 2027</a>
With the new U.S. regulations, Intel might be compelled to divest from some investments, although exemptions for certain venture transactions are being considered.
Meanwhile, Intel secured a <a target="_blank" href="https://www.benzinga.com/general/politics/24/03/37852118/intels-chips-act-funding-could-mean-profits-for-3-congress-members" rel="noreferrer noopener">substantial $20 billion in U.S. government</a> grants and loans in March to expand its domestic semiconductor production, reflecting the significant support for the U.S. chip industry under the 2022 Chips and Science Act.
Intel's large-scale operations in China, employing around 12,000 people and contributing 27% of its global revenue in 2023, illustrate the intricate ties between the U.S. tech giant and the Chinese market.
Intel stock has lost 0.08% in the last 12 months.
Investors can access the stock via the First Trust Nasdaq Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXL#NASDAQ">FTXL</a>) and Strive&nbsp;U.S.&nbsp;Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOC#NYSE">SHOC</a>).
Price Action: At the last check on Wednesday, INTC shares were trading higher by 2.76% at $35.29.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39734145/intel-invests-in-israeli-ai-construction-startup-buildots-whats-on-the-cards" target="_blank" rel="noreferrer noopener">Intel Invests In Israeli AI Construction Startup Buildots &#8211; What's On The Cards?</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo by Fahroni via Shutterstock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

DermTech

News

Latest news for DermTech (OTC:DMTKQ) Stock